Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Claessens

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
Clinical Chemistry and Laboratory Medicine|March 11, 2025
A survey on measurement and reporting of total testosterone, sex hormone-binding globulin and free testosterone in clinical laboratories in EuropeNick Narinx, Jennifer Afrakoma Nyamaah, Karel David, et al.
Scientific Reports|September 26, 2019
Drivers of AR indifferent anti-androgen resistance in prostate cancer cellsFlorian Handle, Stefan Prekovic, Christine Helsen, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 25, 2015
Endocrine determinants of incident sarcopenia in middle-aged and elderly European menEvelien Gielen, Terence W O'Neill, Stephen R Pye, et al.
Expert Review of Anticancer Therapy|November 23, 2020
Current and emerging therapies for localized high-risk prostate cancerLisa Moris, Gaëtan Devos, Thomas Van den Broeck, et al.
Disease Models & Mechanisms|April 27, 2023
Crosstalk between androgen receptor and WNT/β-catenin signaling causes sex-specific adrenocortical hyperplasia in miceRodanthi Lyraki, Anaëlle Grabek, Amélie Tison, et al.
Molecular Cancer Therapeutics|September 27, 2018
The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate ModelsFlorian Handle, Martin Puhr, Georg Schaefer, et al.
Endocrinology|December 13, 2021
Concordant Androgen-Regulated Expression of Divergent Rhox5 Promoters in Sertoli CellsAnjana Bhardwaj, Abhishek Sohni, Chih-Hong Lou, et al.
Scientific Reports|February 4, 2016
Multidisciplinary investigation links backward-speech trait and working memory through genetic mutationStefan Prekovic, Dušica Filipović Đurđević, Gábor Csifcsák, et al.
Nature Communications|February 7, 2017
Structure of the homodimeric androgen receptor ligand-binding domainMarta Nadal, Stefan Prekovic, Nerea Gallastegui, et al.
BMC Cancer|April 3, 2018
Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trialLorenzo Tosco, Annouschka Laenen, Thomas Gevaert, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
Clinical Chemistry and Laboratory Medicine|March 11, 2025
A survey on measurement and reporting of total testosterone, sex hormone-binding globulin and free testosterone in clinical laboratories in EuropeNick Narinx, Jennifer Afrakoma Nyamaah, Karel David, et al.
Scientific Reports|September 26, 2019
Drivers of AR indifferent anti-androgen resistance in prostate cancer cellsFlorian Handle, Stefan Prekovic, Christine Helsen, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 25, 2015
Endocrine determinants of incident sarcopenia in middle-aged and elderly European menEvelien Gielen, Terence W O'Neill, Stephen R Pye, et al.
Expert Review of Anticancer Therapy|November 23, 2020
Current and emerging therapies for localized high-risk prostate cancerLisa Moris, Gaëtan Devos, Thomas Van den Broeck, et al.
Disease Models & Mechanisms|April 27, 2023
Crosstalk between androgen receptor and WNT/β-catenin signaling causes sex-specific adrenocortical hyperplasia in miceRodanthi Lyraki, Anaëlle Grabek, Amélie Tison, et al.
Molecular Cancer Therapeutics|September 27, 2018
The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate ModelsFlorian Handle, Martin Puhr, Georg Schaefer, et al.
Endocrinology|December 13, 2021
Concordant Androgen-Regulated Expression of Divergent Rhox5 Promoters in Sertoli CellsAnjana Bhardwaj, Abhishek Sohni, Chih-Hong Lou, et al.
Scientific Reports|February 4, 2016
Multidisciplinary investigation links backward-speech trait and working memory through genetic mutationStefan Prekovic, Dušica Filipović Đurđević, Gábor Csifcsák, et al.
Nature Communications|February 7, 2017
Structure of the homodimeric androgen receptor ligand-binding domainMarta Nadal, Stefan Prekovic, Nerea Gallastegui, et al.
BMC Cancer|April 3, 2018
Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trialLorenzo Tosco, Annouschka Laenen, Thomas Gevaert, et al.
Pageof 18